Clinical Study
Sorafenib in Advanced Hepatocellular Carcinoma: A Nationwide Retrospective Study of Efficacy and Tolerability
Table 2
Response to sorafenib treatment in patients with advanced HCC according to the intention to treat analysis (ITT) and in patients treated for at least 3 months.
| ||||||||||||||||||||||||||||||
Response evaluated in patients completing 3 months of sorafenib therapy. |